NewsPost Brexit Transition

As confirmed by Senior Inspector, Kiernan Trevett, at the MHRA GPvP Symposium, the MAHs must appoint a UK QPPV within 21 months of the end of the Brexit transition period (21 months after the 01/JAN/2021, unless extended).

The UK QPPV‘s roles and responsibilities shall be equivalent to that of the EU/EEA QPPV. Further guidance on the role and qualifications of the EU/EEA QPPV is outlined in GVP Module I – Pharmacovigilance systems and their quality management systems.

Contact us now to discuss the detailed requirements towards UK QPPV – we are ready to guide to or help you establish your PV system in the UK.